Hao Yu-Fei, Shi Yu, Zheng Jin-Xiu, Zhao Xue-Ting, Liu Sheng-Lu, Yang Li-Jun
Department of Pharmacology,Shanxi Medical University,Taiyuan 030001,China.
Key Laboratory of Tumor Immunology and Targeted Drug Development of Shanxi Province,Shanxi Medical University,Taiyuan 030001,China.
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2024 Oct;46(5):641-652. doi: 10.3881/j.issn.1000-503X.16003.
Objective To explore the effects of proteasome 20S subunit beta 8 (PSMB8) on the proliferation,migration,and invasion of clear cell renal cell carcinoma (ccRCC) cells and whether PSMB8 promotes tumor progression by activating the mitogen-activated protein kinase kinase (MEK)/extracellular signal-regulated kinase (ERK) signaling pathway. Methods The Cancer Genome Atlas was employed to analyze the mRNA levels of PSMB8 in ccRCC and normal tissue,and the expression levels of PSMB8 in ccRCC tissue and cells were determined by real-time quantitative PCR,Western blotting,and immunohistochemistry.Furthermore,the cell lines with stable overexpression and knockdown of PSMB8 were constructed.The CCK-8 assay and colony formation assay were employed to examine the cell proliferation,and the wound healing assay and Transwell assay were employed to examine the invasion and migration of cells.Kyoto Encyclopedia of Genes and Genomes pathway enrichment was performed to analyze the co-expressed genes of PSMB8.Western blotting was used to measure the phosphorylation levels of the proteins in the MEK/ERK signaling pathway.Finally,the rescue experiment was carried out with the ERK agonist C16-PAF. Results Compared with the normal tissue,the ccRCC tissue showed up-regulated mRNA and protein levels of PSMB8 (both <0.001),which were associated with the TNM stage of patients with ccRCC (<0.001).Compared with the negative control group,overexpression of PSMB8 promoted the proliferation (=0.021,=0.039),migration and invasion (all <0.001) of 786-O and ACHN cells,and the knockdown of PSMB8 inhibited the proliferation (=0.022,=0.005),migration and invasion (all <0.001) of 786-O and ACHN cells.The pathway enrichment analysis of co-expressed genes of PSMB8 predicted the mitogen-activated protein kinase signaling pathway (<0.001).After the knockdown of PSMB8,786-O and ACHN cells showed lowered phosphorylation levels of MEK1/2 (=0.017,=0.016) and ERK1/2 (=0.010,=0.040) and down-regulated transcription levels of ERK downstream factors c-Myc (=0.043,=0.038),c-Fos (=0.025,=0.008),and CyclinD1 (=0.006,=0.047).Compared with the ERK agonist C16-PAF group,the PSMB8 knockdown + C16-PAF group showed inhibited proliferation (=0.003,=0.002),migration and invasion (all <0.001) of 786-O and ACHN cells. Conclusion PSMB8 may promote the proliferation,migration,and invasion of ccRCC cells by activating the MEK/ERK signaling pathway.
目的 探讨蛋白酶体20S亚基β8(PSMB8)对肾透明细胞癌(ccRCC)细胞增殖、迁移和侵袭的影响,以及PSMB8是否通过激活丝裂原活化蛋白激酶激酶(MEK)/细胞外信号调节激酶(ERK)信号通路促进肿瘤进展。方法 利用癌症基因组图谱分析ccRCC和正常组织中PSMB8的mRNA水平,通过实时定量PCR、蛋白质印迹法和免疫组织化学法检测ccRCC组织和细胞中PSMB8的表达水平。此外,构建了PSMB8稳定过表达和敲低的细胞系。采用CCK-8法和集落形成试验检测细胞增殖,采用伤口愈合试验和Transwell试验检测细胞的侵袭和迁移。进行京都基因与基因组百科全书通路富集分析以分析PSMB8的共表达基因。用蛋白质印迹法检测MEK/ERK信号通路中蛋白的磷酸化水平。最后,用ERK激动剂C16-PAF进行挽救实验。结果 与正常组织相比,ccRCC组织中PSMB8的mRNA和蛋白水平均上调(均<0.001),这与ccRCC患者的TNM分期相关(<0.001)。与阴性对照组相比,PSMB8过表达促进了786-O和ACHN细胞的增殖(=0.021,=0.039)、迁移和侵袭(均<0.001),而PSMB8敲低则抑制了786-O和ACHN细胞的增殖(=0.022,=0.005)、迁移和侵袭(均<0.001)。对PSMB8共表达基因的通路富集分析预测了丝裂原活化蛋白激酶信号通路(<0.001)。PSMB8敲低后,786-O和ACHN细胞中MEK1/2(=0.017,=0.016)和ERK1/2(=0.010,=0.040)的磷酸化水平降低,ERK下游因子c-Myc(=0.043,=0.038)、c-Fos(=0.025,=0.008)和细胞周期蛋白D1(=0.006,=0.047)的转录水平下调。与ERK激动剂C16-PAF组相比,PSMB8敲低+C16-PAF组中786-O和ACHN细胞的增殖(=0.003,=0.002)、迁移和侵袭(均<0.001)受到抑制。结论 PSMB8可能通过激活MEK/ERK信号通路促进ccRCC细胞的增殖、迁移和侵袭。